233 related articles for article (PubMed ID: 10373334)
1. Reduced efficacy of 8-OH-DPAT's inhibition of lordosis behavior by prior estrogen treatment.
Trevino A; Wolf A; Jackson A; Price T; Uphouse L
Horm Behav; 1999 Jun; 35(3):215-23. PubMed ID: 10373334
[TBL] [Abstract][Full Text] [Related]
2. Prior treatment with estrogen attenuates the effects of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
Jackson A; Uphouse L
Horm Behav; 1996 Jun; 30(2):145-52. PubMed ID: 8797023
[TBL] [Abstract][Full Text] [Related]
3. GABAA-5-HT1A receptor interaction in the mediobasal hypothalamus.
Guptarak J; Selvamani A; Uphouse L
Brain Res; 2004 Nov; 1027(1-2):144-50. PubMed ID: 15494165
[TBL] [Abstract][Full Text] [Related]
4. WAY100635 and female rat lordosis behavior.
Uphouse L; Wolf A
Brain Res; 2004 Jul; 1013(2):260-3. PubMed ID: 15193537
[TBL] [Abstract][Full Text] [Related]
5. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
Truitt W; Harrison L; Guptarak J; White S; Hiegel C; Uphouse L
Brain Res; 2003 Jun; 974(1-2):202-11. PubMed ID: 12742638
[TBL] [Abstract][Full Text] [Related]
6. Factors elevating cAMP attenuate the effects of 8-OH-DPAT on lordosis behavior.
Uphouse L; Maswood S; Jackson A
Pharmacol Biochem Behav; 2000 Jun; 66(2):383-8. PubMed ID: 10880694
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN.
Uphouse L; Caldarola-Pastuszka M; Maswood S; Andrade M; Moore N
Brain Res; 1994 Feb; 637(1-2):173-80. PubMed ID: 8180795
[TBL] [Abstract][Full Text] [Related]
8. Estrogen reduces serotonin-1A receptor-mediated oxytocin release and Galpha(i/o/z) proteins in the hypothalamus of ovariectomized rats.
D'Souza DN; Zhang Y; Damjanoska KJ; Carrasco GA; Sullivan NR; Garcia F; Battaglia G; Doncarlos LL; Muma NA; Van de Kar LD
Neuroendocrinology; 2004; 80(1):31-41. PubMed ID: 15385710
[TBL] [Abstract][Full Text] [Related]
9. Estrogen modulates 5-HT(1A) agonist inhibition of lordosis behavior but not binding of [(3)H]-8-OH-DPAT.
Jackson A; Etgen AM
Pharmacol Biochem Behav; 2001 Feb; 68(2):221-7. PubMed ID: 11267626
[TBL] [Abstract][Full Text] [Related]
10. Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.
Le Saux M; Di Paolo T
J Psychiatry Neurosci; 2005 Mar; 30(2):110-7. PubMed ID: 15798786
[TBL] [Abstract][Full Text] [Related]
11. Strain differences in the response to the 5-HT1A receptor agonist, 8-OH-DPAT.
Uphouse L; Maswood S; Jackson A; Brown K; Prullage J; Myers T; Shaheen F
Pharmacol Biochem Behav; 2002 Jun; 72(3):533-42. PubMed ID: 12175449
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent effects of estradiol benzoate on 5-HT1A receptor agonist action.
Jackson A; Uphouse L
Brain Res; 1998 Jun; 796(1-2):299-302. PubMed ID: 9689482
[TBL] [Abstract][Full Text] [Related]
13. The PKC inhibitor, bisindolymaleimide, blocks DOI's attenuation of the effects of 8-OH-DPAT on female rat lordosis behavior.
Selvamani A; Lincoln C; Uphouse L
Behav Brain Res; 2007 Apr; 179(1):99-106. PubMed ID: 17336403
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
Misane I; Johansson C; Ogren SO
Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
[TBL] [Abstract][Full Text] [Related]
15. 5-HT1A receptor antagonists and lordosis behavior.
Uphouse L; Andrade M; Caldarola-Pastuszka M; Jackson A
Neuropharmacology; 1996 Apr; 35(4):489-95. PubMed ID: 8793912
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lordosis in female hamsters and rats by 8-OH-DPAT treatment.
Hebert TJ; Menard CS; Dohanich GP
Physiol Behav; 1995 Mar; 57(3):523-7. PubMed ID: 7753891
[TBL] [Abstract][Full Text] [Related]
17. Estrogen increases the bradycardia elicited by central administration of the serotonin1A agonist 8-OH-DPAT in conscious rats.
Alper RH; Schmitz TM
Brain Res; 1996 Apr; 716(1-2):224-8. PubMed ID: 8738244
[TBL] [Abstract][Full Text] [Related]
18. Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior.
Uphouse L; White S; Harrison L; Hiegel C; Majumdar D; Guptarak J; Truitt WA
Pharmacol Biochem Behav; 2003 Aug; 76(1):63-73. PubMed ID: 13679218
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic infusion of the 5-HT2/1C agonist, DOI, prevents the inhibitory actions of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
Uphouse L; Andrade M; Caldarola-Pastuszka M; Maswood S
Pharmacol Biochem Behav; 1994 Mar; 47(3):467-70. PubMed ID: 8208763
[TBL] [Abstract][Full Text] [Related]
20. Anxiogenesis in adult rats treated chronically with cocaine during adolescence: effects of extended abstinence and 8-OH-DPAT treatment.
Santucci AC; Madeira E
Brain Res Bull; 2008 Jul; 76(4):402-11. PubMed ID: 18502317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
